{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:35:31Z","timestamp":1770417331671,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFD0500902"],"award-info":[{"award-number":["2017YFD0500902"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31201943"],"award-info":[{"award-number":["31201943"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31572522"],"award-info":[{"award-number":["31572522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005196","name":"Fundamental Research Funds of the Chinese Academy of Agricultural Sciences","doi-asserted-by":"publisher","award":["1610312016026"],"award-info":[{"award-number":["1610312016026"]}],"id":[{"id":"10.13039\/501100005196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.032","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T07:31:25Z","timestamp":1551079885000},"page":"2016-2025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability"],"prefix":"10.1016","volume":"37","author":[{"given":"Yinli","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingcai","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.032_b0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.02.032_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0168-1702(02)00259-9","article-title":"Evolution of foot-and-mouth disease virus","volume":"91","author":"Domingo","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.02.032_b0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","article-title":"The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?","volume":"112","author":"Knight-Jones","year":"2013","journal-title":"Prevent Veterinary Med"},{"key":"10.1016\/j.vaccine.2019.02.032_b0020","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1128\/JVI.79.10.6487-6504.2005","article-title":"Comparative genomics of foot-and-mouth disease virus","volume":"79","author":"Carrillo","year":"2005","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2019.02.032_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2001106","article-title":"Foot-and-mouth disease virus: a long known virus, but a current threat","volume":"32","author":"Sobrino","year":"2001","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.02.032_b0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.vaccine.2019.02.032_b0035","first-page":"71","article-title":"The structure of foot-and-mouth disease virus","volume":"288","author":"Fry","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01320790","article-title":"Thermal stability of foot-and-mouth disease virus","volume":"70","author":"Doel","year":"1981","journal-title":"Arch Virol."},{"key":"10.1016\/j.vaccine.2019.02.032_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01314726","article-title":"Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus","volume":"73","author":"Doel","year":"1982","journal-title":"Arch Virol."},{"key":"10.1016\/j.vaccine.2019.02.032_b0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/1921163a0","article-title":"Dissociation of foot-and-mouth disease virus into its nucleic acid and protein components","volume":"192","author":"Brown","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.02.032_b0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/JVI.69.1.430-438.1995","article-title":"Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids","volume":"69","author":"Curry","year":"1995","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2019.02.032_b0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/jmbi.1997.1418","article-title":"Titration calculations of foot-and-mouth disease virus capsids and their stabilities as a function of pH","volume":"275","author":"van Vlijmen","year":"1998","journal-title":"J Mol Biol"},{"issue":"82","key":"10.1016\/j.vaccine.2019.02.032_b0065","first-page":"444","article-title":"Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease","volume":"1959","author":"Brown","year":"1950","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"10.1016\/j.vaccine.2019.02.032_b0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1099\/0022-1317-45-3-761","article-title":"Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses","volume":"45","author":"Meloen","year":"1979","journal-title":"J General Virol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0378-1135(94)90094-9","article-title":"Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1","volume":"39","author":"Rao","year":"1994","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0080","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.vaccine.2011.01.069","article-title":"Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles","volume":"29","author":"Harmsen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.032_b0085","doi-asserted-by":"crossref","first-page":"e1003255","DOI":"10.1371\/journal.ppat.1003255","article-title":"Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen","volume":"9","author":"Porta","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.02.032_b0090","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/JVI.03222-13","article-title":"An increase in acid resistance of foot-and-mouth disease virus capsid is mediated by a tyrosine replacement of the VP2 histidine previously associated with VP0 cleavage","volume":"88","author":"Vazquez-Calvo","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0095","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1128\/JVI.01553-08","article-title":"Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines","volume":"82","author":"Mateo","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0100","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02312-16","article-title":"SAT2 foot-and-mouth disease virus structurally modified for increased thermostability","volume":"91","author":"Scott","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.vetmic.2017.03.031","article-title":"Preserved immunogenicity of an inactivated vaccine based on foot-and-mouth disease virus particles with improved stability","volume":"203","author":"Caridi","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0110","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1128\/JVI.03358-14","article-title":"The pH stability of foot-and-mouth disease virus particles is modulated by residues located at the pentameric interface and in the N terminus of VP1","volume":"89","author":"Caridi","year":"2015","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2019.02.032_b0115","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JVI.02245-10","article-title":"A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance","volume":"85","author":"Martin-Acebes","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00705-013-1872-7","article-title":"Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus","volume":"159","author":"Liang","year":"2014","journal-title":"Arch Virol."},{"key":"10.1016\/j.vaccine.2019.02.032_b0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12250-014-3426-x","article-title":"Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus","volume":"29","author":"Wang","year":"2014","journal-title":"Virologica Sinica"},{"key":"10.1016\/j.vaccine.2019.02.032_b0130","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/JVI.02311-09","article-title":"A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition","volume":"84","author":"Martin-Acebes","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0135","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3389\/fimmu.2017.00960","article-title":"Isolation of single-domain antibody fragments that preferentially detect intact (146S) particles of foot-and-mouth disease virus for use in vaccine quality control","volume":"8","author":"Harmsen","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0140","doi-asserted-by":"crossref","first-page":"e2273","DOI":"10.1371\/journal.pone.0002273","article-title":"Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine","volume":"3","author":"Li","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.02.032_b0145","doi-asserted-by":"crossref","first-page":"7849203","DOI":"10.1155\/2016\/7849203","article-title":"A recombinant adenovirus expressing P12A and 3C protein of the type O foot-and-mouth disease virus stimulates systemic and mucosal immune responses in mice","volume":"2016","author":"Xie","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.vaccine.2019.02.032_b0150","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1038\/emi.2014.49","article-title":"Receptors for enterovirus 71","volume":"3","author":"Yamayoshi","year":"2014","journal-title":"Emerging Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.02.032_b0155","article-title":"Challenges and prospects for the control of foot-and-mouth disease: An African perspective","author":"Rweyemamu","year":"2014","journal-title":"J Vet Med Res Rep"},{"key":"10.1016\/j.vaccine.2019.02.032_b0160","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0264-410X(94)90262-3","article-title":"Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state","volume":"12","author":"Doel","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.032_b0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0264-410X(87)90011-9","article-title":"Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines","volume":"5","author":"Pay","year":"1987","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.032_b0170","series-title":"Advanced Technologies for Protein Complex Production and Characterization","first-page":"199","article-title":"The multibac baculovirus\/insect cell expression vector system for producing complex protein biologics. advances in experimental medicine and biology","author":"Sari","year":"2016"},{"key":"10.1016\/j.vaccine.2019.02.032_b0175","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00253-013-5474-9","article-title":"Suitability and perspectives on using recombinant insect cells for the production of virus-like particles","volume":"98","author":"Yamaji","year":"2014","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/erv.12.153","article-title":"Insect cells as a production platform of complex virus-like particles","volume":"12","author":"Fernandes","year":"2013","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.02.032_b0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pep.2013.05.009","article-title":"Use of baculovirus expression system for generation of virus-like particles: successes and challenges","volume":"90","author":"Liu","year":"2013","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2019.02.032_b0190","doi-asserted-by":"crossref","first-page":"e43849","DOI":"10.1371\/journal.pone.0043849","article-title":"Development of a foot-and-mouth disease virus serotype a empty capsid subunit vaccine using silkworm (Bombyx mori) pupae","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.02.032_b0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vetmic.2010.10.022","article-title":"FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle","volume":"149","author":"Li","year":"2011","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0200","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.rvsc.2013.07.007","article-title":"Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge","volume":"95","author":"Bhat","year":"2013","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2019.02.032_b0205","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1016\/j.vaccine.2011.10.037","article-title":"Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response","volume":"29","author":"Moraes","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.032_b0210","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1966","article-title":"Interplay of foot and mouth disease virus with cell-mediated and humoral immunity of host","volume":"28","author":"Abubakar","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2019.02.032_b0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/viro.1999.9717","article-title":"Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs","volume":"259","author":"Sanz-Parra","year":"1999","journal-title":"Virology"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2019.02.032_b0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1099\/0022-1317-80-3-671","article-title":"Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins","volume":"80","author":"Sanz-Parra","year":"1999","journal-title":"J General Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T13:28:22Z","timestamp":1606570102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19302270"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}